 | • レポートコード：QYR2104Z5209 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、性索性腺間質腫瘍のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院用、診療所用、研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・性索性腺間質腫瘍の市場動向 ・企業の競争状況、市場シェア ・性索性腺間質腫瘍の種類別市場規模（診断、治療） ・性索性腺間質腫瘍の用途別市場規模（病院用、診療所用、研究センター、その他） ・性索性腺間質腫瘍の北米市場規模2016-2027（アメリカ、カナダ） ・性索性腺間質腫瘍のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・性索性腺間質腫瘍のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・性索性腺間質腫瘍の中南米市場規模2016-2027（メキシコ、ブラジル） ・性索性腺間質腫瘍の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott, Abcam plc.、Affymetrix, Inc.、Agilent Technologies, Inc.、Beckman Dickinson and Company、Bio SB Inc.、BioCurex、BioModa, Inc.、Bio-Rad Laboratories, Inc.、Boston Scientific Corporation、Cell Signaling Technology, Inc.、Clarient, Inc.、CooperSurgical Inc.、Correlogic Systems, Inc.、Danaher Corporation、Epigenomics AG） ・結論 |
The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, gynandroblastoma, Sex Cord Tumor with Annular Tubules (SCTAT), and Sertoli Leydig cell tumor. In humans, this type of tumor accounts for 8% of the ovarian cancers and around 5% of testicular cancers.
The Americas dominates the sex cord-gonadal stromal tumor market owing to the increasing prevalence of ovarian cancer in this region and high healthcare expenditure.
Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Market
The global Sex Cord Gonadal Stromal Tumor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sex Cord Gonadal Stromal Tumor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sex Cord Gonadal Stromal Tumor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sex Cord Gonadal Stromal Tumor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sex Cord Gonadal Stromal Tumor market.
Global Sex Cord Gonadal Stromal Tumor Scope and Market Size
Sex Cord Gonadal Stromal Tumor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sex Cord Gonadal Stromal Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospital Use
Clinic Use
Research Center
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott, Abcam plc.
Affymetrix, Inc.
Agilent Technologies, Inc.
Beckman Dickinson and Company
Bio SB Inc.
BioCurex
BioModa, Inc.
Bio-Rad Laboratories, Inc.
Boston Scientific Corporation
Beckman Dickinson and Company
Bio SB Inc.
CooperSurgical Inc.
Correlogic Systems, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sex Cord Gonadal Stromal Tumor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Sex Cord Gonadal Stromal Tumor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Research Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sex Cord Gonadal Stromal Tumor Market Perspective (2016-2027)
2.2 Sex Cord Gonadal Stromal Tumor Growth Trends by Regions
2.2.1 Sex Cord Gonadal Stromal Tumor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sex Cord Gonadal Stromal Tumor Historic Market Share by Regions (2016-2021)
2.2.3 Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Regions (2022-2027)
2.3 Sex Cord Gonadal Stromal Tumor Industry Dynamic
2.3.1 Sex Cord Gonadal Stromal Tumor Market Trends
2.3.2 Sex Cord Gonadal Stromal Tumor Market Drivers
2.3.3 Sex Cord Gonadal Stromal Tumor Market Challenges
2.3.4 Sex Cord Gonadal Stromal Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sex Cord Gonadal Stromal Tumor Players by Revenue
3.1.1 Global Top Sex Cord Gonadal Stromal Tumor Players by Revenue (2016-2021)
3.1.2 Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Players (2016-2021)
3.2 Global Sex Cord Gonadal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sex Cord Gonadal Stromal Tumor Revenue
3.4 Global Sex Cord Gonadal Stromal Tumor Market Concentration Ratio
3.4.1 Global Sex Cord Gonadal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sex Cord Gonadal Stromal Tumor Revenue in 2020
3.5 Sex Cord Gonadal Stromal Tumor Key Players Head office and Area Served
3.6 Key Players Sex Cord Gonadal Stromal Tumor Product Solution and Service
3.7 Date of Enter into Sex Cord Gonadal Stromal Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sex Cord Gonadal Stromal Tumor Breakdown Data by Type
4.1 Global Sex Cord Gonadal Stromal Tumor Historic Market Size by Type (2016-2021)
4.2 Global Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Type (2022-2027)
5 Sex Cord Gonadal Stromal Tumor Breakdown Data by Application
5.1 Global Sex Cord Gonadal Stromal Tumor Historic Market Size by Application (2016-2021)
5.2 Global Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sex Cord Gonadal Stromal Tumor Market Size (2016-2027)
6.2 North America Sex Cord Gonadal Stromal Tumor Market Size by Type
6.2.1 North America Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021)
6.2.2 North America Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027)
6.2.3 North America Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2027)
6.3 North America Sex Cord Gonadal Stromal Tumor Market Size by Application
6.3.1 North America Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021)
6.3.2 North America Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027)
6.3.3 North America Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2027)
6.4 North America Sex Cord Gonadal Stromal Tumor Market Size by Country
6.4.1 North America Sex Cord Gonadal Stromal Tumor Market Size by Country (2016-2021)
6.4.2 North America Sex Cord Gonadal Stromal Tumor Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Sex Cord Gonadal Stromal Tumor Market Size (2016-2027)
7.2 Europe Sex Cord Gonadal Stromal Tumor Market Size by Type
7.2.1 Europe Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021)
7.2.2 Europe Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027)
7.2.3 Europe Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2027)
7.3 Europe Sex Cord Gonadal Stromal Tumor Market Size by Application
7.3.1 Europe Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021)
7.3.2 Europe Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027)
7.3.3 Europe Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2027)
7.4 Europe Sex Cord Gonadal Stromal Tumor Market Size by Country
7.4.1 Europe Sex Cord Gonadal Stromal Tumor Market Size by Country (2016-2021)
7.4.2 Europe Sex Cord Gonadal Stromal Tumor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size (2016-2027)
8.2 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Type
8.2.1 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2027)
8.3 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Application
8.3.1 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2027)
8.4 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Region
8.4.1 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sex Cord Gonadal Stromal Tumor Market Size (2016-2027)
9.2 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Type
9.2.1 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021)
9.2.2 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027)
9.2.3 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2027)
9.3 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Application
9.3.1 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021)
9.3.2 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027)
9.3.3 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2027)
9.4 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Country
9.4.1 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Country (2016-2021)
9.4.2 Latin America Sex Cord Gonadal Stromal Tumor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size (2016-2027)
10.2 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Type
10.2.1 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2027)
10.3 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Application
10.3.1 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2027)
10.4 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Country
10.4.1 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott, Abcam plc.
11.1.1 Abbott, Abcam plc. Company Details
11.1.2 Abbott, Abcam plc. Business Overview
11.1.3 Abbott, Abcam plc. Sex Cord Gonadal Stromal Tumor Introduction
11.1.4 Abbott, Abcam plc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.1.5 Abbott, Abcam plc. Recent Development
11.2 Affymetrix, Inc.
11.2.1 Affymetrix, Inc. Company Details
11.2.2 Affymetrix, Inc. Business Overview
11.2.3 Affymetrix, Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.2.4 Affymetrix, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.2.5 Affymetrix, Inc. Recent Development
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Details
11.3.2 Agilent Technologies, Inc. Business Overview
11.3.3 Agilent Technologies, Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.3.4 Agilent Technologies, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.3.5 Agilent Technologies, Inc. Recent Development
11.4 Beckman Dickinson and Company
11.4.1 Beckman Dickinson and Company Company Details
11.4.2 Beckman Dickinson and Company Business Overview
11.4.3 Beckman Dickinson and Company Sex Cord Gonadal Stromal Tumor Introduction
11.4.4 Beckman Dickinson and Company Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.4.5 Beckman Dickinson and Company Recent Development
11.5 Bio SB Inc.
11.5.1 Bio SB Inc. Company Details
11.5.2 Bio SB Inc. Business Overview
11.5.3 Bio SB Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.5.4 Bio SB Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.5.5 Bio SB Inc. Recent Development
11.6 BioCurex
11.6.1 BioCurex Company Details
11.6.2 BioCurex Business Overview
11.6.3 BioCurex Sex Cord Gonadal Stromal Tumor Introduction
11.6.4 BioCurex Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.6.5 BioCurex Recent Development
11.7 BioModa, Inc.
11.7.1 BioModa, Inc. Company Details
11.7.2 BioModa, Inc. Business Overview
11.7.3 BioModa, Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.7.4 BioModa, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.7.5 BioModa, Inc. Recent Development
11.8 Bio-Rad Laboratories, Inc.
11.8.1 Bio-Rad Laboratories, Inc. Company Details
11.8.2 Bio-Rad Laboratories, Inc. Business Overview
11.8.3 Bio-Rad Laboratories, Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.8.4 Bio-Rad Laboratories, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.8.5 Bio-Rad Laboratories, Inc. Recent Development
11.9 Boston Scientific Corporation
11.9.1 Boston Scientific Corporation Company Details
11.9.2 Boston Scientific Corporation Business Overview
11.9.3 Boston Scientific Corporation Sex Cord Gonadal Stromal Tumor Introduction
11.9.4 Boston Scientific Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.9.5 Boston Scientific Corporation Recent Development
11.10 Cell Signaling Technology, Inc.
11.10.1 Cell Signaling Technology, Inc. Company Details
11.10.2 Cell Signaling Technology, Inc. Business Overview
11.10.3 Cell Signaling Technology, Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.10.4 Cell Signaling Technology, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.10.5 Cell Signaling Technology, Inc. Recent Development
11.11 Clarient, Inc.
11.11.1 Clarient, Inc. Company Details
11.11.2 Clarient, Inc. Business Overview
11.11.3 Clarient, Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.11.4 Clarient, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.11.5 Clarient, Inc. Recent Development
11.12 CooperSurgical Inc.
11.12.1 CooperSurgical Inc. Company Details
11.12.2 CooperSurgical Inc. Business Overview
11.12.3 CooperSurgical Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.12.4 CooperSurgical Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.12.5 CooperSurgical Inc. Recent Development
11.13 Correlogic Systems, Inc.
11.13.1 Correlogic Systems, Inc. Company Details
11.13.2 Correlogic Systems, Inc. Business Overview
11.13.3 Correlogic Systems, Inc. Sex Cord Gonadal Stromal Tumor Introduction
11.13.4 Correlogic Systems, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.13.5 Correlogic Systems, Inc. Recent Development
11.14 Danaher Corporation
11.14.1 Danaher Corporation Company Details
11.14.2 Danaher Corporation Business Overview
11.14.3 Danaher Corporation Sex Cord Gonadal Stromal Tumor Introduction
11.14.4 Danaher Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.14.5 Danaher Corporation Recent Development
11.15 Epigenomics AG
11.15.1 Epigenomics AG Company Details
11.15.2 Epigenomics AG Business Overview
11.15.3 Epigenomics AG Sex Cord Gonadal Stromal Tumor Introduction
11.15.4 Epigenomics AG Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
11.15.5 Epigenomics AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sex Cord Gonadal Stromal Tumor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Sex Cord Gonadal Stromal Tumor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Sex Cord Gonadal Stromal Tumor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sex Cord Gonadal Stromal Tumor Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Sex Cord Gonadal Stromal Tumor Market Share by Regions (2016-2021)
Table 8. Global Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Sex Cord Gonadal Stromal Tumor Market Share by Regions (2022-2027)
Table 10. Sex Cord Gonadal Stromal Tumor Market Trends
Table 11. Sex Cord Gonadal Stromal Tumor Market Drivers
Table 12. Sex Cord Gonadal Stromal Tumor Market Challenges
Table 13. Sex Cord Gonadal Stromal Tumor Market Restraints
Table 14. Global Sex Cord Gonadal Stromal Tumor Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Sex Cord Gonadal Stromal Tumor Market Share by Players (2016-2021)
Table 16. Global Top Sex Cord Gonadal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sex Cord Gonadal Stromal Tumor as of 2020)
Table 17. Ranking of Global Top Sex Cord Gonadal Stromal Tumor Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Sex Cord Gonadal Stromal Tumor Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sex Cord Gonadal Stromal Tumor Product Solution and Service
Table 21. Date of Enter into Sex Cord Gonadal Stromal Tumor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Type (2016-2021)
Table 25. Global Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Sex Cord Gonadal Stromal Tumor Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Application (2016-2021)
Table 29. Global Sex Cord Gonadal Stromal Tumor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Sex Cord Gonadal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Sex Cord Gonadal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Sex Cord Gonadal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Sex Cord Gonadal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Sex Cord Gonadal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Sex Cord Gonadal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott, Abcam plc. Company Details
Table 62. Abbott, Abcam plc. Business Overview
Table 63. Abbott, Abcam plc. Sex Cord Gonadal Stromal Tumor Product
Table 64. Abbott, Abcam plc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 65. Abbott, Abcam plc. Recent Development
Table 66. Affymetrix, Inc. Company Details
Table 67. Affymetrix, Inc. Business Overview
Table 68. Affymetrix, Inc. Sex Cord Gonadal Stromal Tumor Product
Table 69. Affymetrix, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 70. Affymetrix, Inc. Recent Development
Table 71. Agilent Technologies, Inc. Company Details
Table 72. Agilent Technologies, Inc. Business Overview
Table 73. Agilent Technologies, Inc. Sex Cord Gonadal Stromal Tumor Product
Table 74. Agilent Technologies, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 75. Agilent Technologies, Inc. Recent Development
Table 76. Beckman Dickinson and Company Company Details
Table 77. Beckman Dickinson and Company Business Overview
Table 78. Beckman Dickinson and Company Sex Cord Gonadal Stromal Tumor Product
Table 79. Beckman Dickinson and Company Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 80. Beckman Dickinson and Company Recent Development
Table 81. Bio SB Inc. Company Details
Table 82. Bio SB Inc. Business Overview
Table 83. Bio SB Inc. Sex Cord Gonadal Stromal Tumor Product
Table 84. Bio SB Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 85. Bio SB Inc. Recent Development
Table 86. BioCurex Company Details
Table 87. BioCurex Business Overview
Table 88. BioCurex Sex Cord Gonadal Stromal Tumor Product
Table 89. BioCurex Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 90. BioCurex Recent Development
Table 91. BioModa, Inc. Company Details
Table 92. BioModa, Inc. Business Overview
Table 93. BioModa, Inc. Sex Cord Gonadal Stromal Tumor Product
Table 94. BioModa, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 95. BioModa, Inc. Recent Development
Table 96. Bio-Rad Laboratories, Inc. Company Details
Table 97. Bio-Rad Laboratories, Inc. Business Overview
Table 98. Bio-Rad Laboratories, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 99. Bio-Rad Laboratories, Inc. Recent Development
Table 100. Boston Scientific Corporation Company Details
Table 101. Boston Scientific Corporation Business Overview
Table 102. Boston Scientific Corporation Sex Cord Gonadal Stromal Tumor Product
Table 103. Boston Scientific Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 104. Boston Scientific Corporation Recent Development
Table 105. Cell Signaling Technology, Inc. Company Details
Table 106. Cell Signaling Technology, Inc. Business Overview
Table 107. Cell Signaling Technology, Inc. Sex Cord Gonadal Stromal Tumor Product
Table 108. Cell Signaling Technology, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 109. Cell Signaling Technology, Inc. Recent Development
Table 110. Clarient, Inc. Company Details
Table 111. Clarient, Inc. Business Overview
Table 112. Clarient, Inc. Sex Cord Gonadal Stromal Tumor Product
Table 113. Clarient, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 114. Clarient, Inc. Recent Development
Table 115. CooperSurgical Inc. Company Details
Table 116. CooperSurgical Inc. Business Overview
Table 117. CooperSurgical Inc. Sex Cord Gonadal Stromal Tumor Product
Table 118. CooperSurgical Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 119. CooperSurgical Inc. Recent Development
Table 120. Correlogic Systems, Inc. Company Details
Table 121. Correlogic Systems, Inc. Business Overview
Table 122. Correlogic Systems, Inc. Sex Cord Gonadal Stromal Tumor Product
Table 123. Correlogic Systems, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 124. Correlogic Systems, Inc. Recent Development
Table 125. Danaher Corporation Company Details
Table 126. Danaher Corporation Business Overview
Table 127. Danaher Corporation Sex Cord Gonadal Stromal Tumor Product
Table 128. Danaher Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 129. Danaher Corporation Recent Development
Table 130. Epigenomics AG Company Details
Table 131. Epigenomics AG Business Overview
Table 132. Epigenomics AG Sex Cord Gonadal Stromal Tumor Product
Table 133. Epigenomics AG Revenue in Sex Cord Gonadal Stromal Tumor Business (2016-2021) & (US$ Million)
Table 134. Epigenomics AG Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sex Cord Gonadal Stromal Tumor Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Sex Cord Gonadal Stromal Tumor Market Share by Application: 2020 VS 2027
Figure 5. Hospital Use Case Studies
Figure 6. Clinic Use Case Studies
Figure 7. Research Center Case Studies
Figure 8. Other Case Studies
Figure 9. Sex Cord Gonadal Stromal Tumor Report Years Considered
Figure 10. Global Sex Cord Gonadal Stromal Tumor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Sex Cord Gonadal Stromal Tumor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Sex Cord Gonadal Stromal Tumor Market Share by Regions: 2020 VS 2027
Figure 13. Global Sex Cord Gonadal Stromal Tumor Market Share by Regions (2022-2027)
Figure 14. Global Sex Cord Gonadal Stromal Tumor Market Share by Players in 2020
Figure 15. Global Top Sex Cord Gonadal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sex Cord Gonadal Stromal Tumor as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Sex Cord Gonadal Stromal Tumor Revenue in 2020
Figure 17. Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Type (2016-2021)
Figure 18. Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Type (2022-2027)
Figure 19. North America Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Sex Cord Gonadal Stromal Tumor Market Share by Type (2016-2027)
Figure 21. North America Sex Cord Gonadal Stromal Tumor Market Share by Application (2016-2027)
Figure 22. North America Sex Cord Gonadal Stromal Tumor Market Share by Country (2016-2027)
Figure 23. United States Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Sex Cord Gonadal Stromal Tumor Market Share by Type (2016-2027)
Figure 27. Europe Sex Cord Gonadal Stromal Tumor Market Share by Application (2016-2027)
Figure 28. Europe Sex Cord Gonadal Stromal Tumor Market Share by Country (2016-2027)
Figure 29. Germany Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Sex Cord Gonadal Stromal Tumor Market Share by Region (2016-2027)
Figure 39. China Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Sex Cord Gonadal Stromal Tumor Market Share by Type (2016-2027)
Figure 47. Latin America Sex Cord Gonadal Stromal Tumor Market Share by Application (2016-2027)
Figure 48. Latin America Sex Cord Gonadal Stromal Tumor Market Share by Country (2016-2027)
Figure 49. Mexico Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Sex Cord Gonadal Stromal Tumor Market Share by Country (2016-2027)
Figure 55. Turkey Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Sex Cord Gonadal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott, Abcam plc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 59. Affymetrix, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 60. Agilent Technologies, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 61. Beckman Dickinson and Company Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 62. Bio SB Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 63. BioCurex Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 64. BioModa, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 65. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 66. Boston Scientific Corporation Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 67. Cell Signaling Technology, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 68. Clarient, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 69. CooperSurgical Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 70. Correlogic Systems, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 71. Danaher Corporation Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 72. Epigenomics AG Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の性索性腺間質腫瘍治療市場規模・現状・予測（2021年-2027年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Treatment Market The global Sex Cord Gonadal Strom…- 世界の消化管間質腫瘍市場規模・現状・予測（2021年-2027年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- 世界の消化管間質腫瘍（GIST）治療市場規模・現状・予測（2021年-2027年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
- 世界の間質血管分画市場規模・現状・予測（2021年-2027年） Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body. With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, …
- 世界の交流電場腫瘍治療市場規模・現状・予測（2021年-2027年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…